Analyses among different breast cancer subtypes showed that CXCL9 mRNA levels in tumor tissues were much higher in the TNBC subtypes than in the luminal subtypes (Li et al., 2020; Liang et al., 2021). This evidence concerns the gene CXCL9 and breast cancer.